DANIO-CODE
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
si:ch1073-357b18.4 | dr10_dc_chr12_-_280962_281088 | 0.68 | 3.8e-03 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr16_+_24063849 Show fit | 13.57 |
ENSDART00000135084
|
apolipoprotein A-II |
|
chr25_-_32344881 Show fit | 13.07 |
ENSDART00000012862
|
ISL LIM homeobox 2a |
|
chr19_-_5441932 Show fit | 12.80 |
ENSDART00000105034
|
type I cytokeratin, enveloping layer, like |
|
chr17_+_19479310 Show fit | 11.19 |
ENSDART00000077804
|
solute carrier family 22, member 15 |
|
chr22_-_37414940 Show fit | 10.87 |
ENSDART00000104493
|
SRY (sex determining region Y)-box 2 |
|
chr9_-_47041677 Show fit | 9.49 |
ENSDART00000054137
|
insulin-like growth factor binding protein 5b |
|
chr6_-_39315024 Show fit | 9.41 |
ENSDART00000012644
|
keratin 4 |
|
chr2_+_22324846 Show fit | 9.31 |
ENSDART00000044371
|
thymocyte selection-associated high mobility group box |
|
chr25_-_30845998 Show fit | 8.82 |
ENSDART00000027661
|
myogenic differentiation 1 |
|
chr14_-_24463906 Show fit | 8.61 |
ENSDART00000126199
|
slit homolog 3 (Drosophila) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 26.0 | GO:0006357 | regulation of transcription from RNA polymerase II promoter(GO:0006357) |
0.1 | 17.2 | GO:0045944 | positive regulation of transcription from RNA polymerase II promoter(GO:0045944) |
2.4 | 14.1 | GO:0003311 | pancreatic D cell differentiation(GO:0003311) |
0.1 | 13.6 | GO:0000280 | nuclear division(GO:0000280) |
2.6 | 13.1 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
1.3 | 12.7 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.9 | 12.3 | GO:0036302 | atrioventricular canal development(GO:0036302) |
0.4 | 11.8 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
1.2 | 11.0 | GO:0060114 | vestibular receptor cell differentiation(GO:0060114) vestibular receptor cell development(GO:0060118) |
2.2 | 10.9 | GO:0021982 | pineal gland development(GO:0021982) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 125.4 | GO:0005634 | nucleus(GO:0005634) |
0.0 | 67.5 | GO:0016021 | integral component of membrane(GO:0016021) |
0.1 | 46.6 | GO:0005615 | extracellular space(GO:0005615) |
0.6 | 42.1 | GO:0005882 | intermediate filament(GO:0005882) |
0.1 | 27.2 | GO:0000785 | chromatin(GO:0000785) |
0.1 | 20.2 | GO:0005576 | extracellular region(GO:0005576) |
0.0 | 18.5 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.0 | 17.9 | GO:0043005 | neuron projection(GO:0043005) |
0.2 | 14.3 | GO:0005795 | Golgi stack(GO:0005795) |
0.1 | 13.3 | GO:0005759 | mitochondrial matrix(GO:0005759) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 118.0 | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding(GO:0000981) |
0.1 | 39.4 | GO:0005198 | structural molecule activity(GO:0005198) |
0.1 | 29.5 | GO:0051015 | actin filament binding(GO:0051015) |
1.6 | 14.5 | GO:0048495 | Roundabout binding(GO:0048495) |
2.1 | 14.4 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 14.0 | GO:0003712 | transcription factor activity, transcription factor binding(GO:0000989) transcription cofactor activity(GO:0003712) |
1.3 | 13.4 | GO:0008327 | methyl-CpG binding(GO:0008327) |
1.3 | 12.7 | GO:0031995 | insulin-like growth factor I binding(GO:0031994) insulin-like growth factor II binding(GO:0031995) |
0.0 | 12.1 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.2 | 10.6 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 18.9 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.4 | 14.6 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.2 | 11.0 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.4 | 10.8 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 9.5 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.2 | 9.2 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.5 | 8.3 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 6.9 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.4 | 6.4 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 3.8 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 16.4 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.7 | 14.2 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.7 | 14.0 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
1.7 | 13.6 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
2.8 | 11.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.2 | 10.6 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.5 | 8.6 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
1.0 | 7.2 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 5.0 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.2 | 3.8 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |